🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this clinical study is to determine the effectiveness (abili...
Status
Completed
Location
Comprehensive Blood and Cancer Center
Start Date
2008-01
Trial ID
NCT00606502
Treatments Being Tested
This phase I trial tests the safety, side effects and best dose of azacitid...
Status
Not Yet Recruiting
Location
City of Hope Medical Center
Start Date
2027-01-03
Trial ID
NCT07691450
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2001-05
Trial ID
NCT00024245
Treatments Being Tested
This phase I/II trial studies the side effects and best dose of pralatrexat...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2019-02-04
Trial ID
NCT03598998
Treatments Being Tested
The purpose of this study is to determine the efficacy (ability to provide ...
Status
Completed
Location
Providence Cancer Center
Start Date
2010-03
Trial ID
NCT01118624
Treatments Being Tested
This is a phase 3, randomized, 2-arm, open-label, international trial evalu...
Status
Completed
Location
Multiple Locations
Start Date
2012-06-11
Trial ID
NCT01482962
Treatments Being Tested
The purpose of this study is to determine whether pralatrexate, given with ...
Status
Completed
Location
The University of Arizona Health Sciences Center
Start Date
2008-07
Trial ID
NCT00722553
Treatments Being Tested
The purpose of this study is to find out whether the combination treatment ...
Status
Recruiting
Location
VA Long Beach Health Care System
Start Date
2021-02-19
Trial ID
NCT04747236
Treatments Being Tested
This study is to evaluate the objective response rate to pralatrexate in As...
Status
Unknown
Location
Ntional Taiwan University Hospital
Start Date
2016-08-30
Trial ID
NCT03150602
Treatments Being Tested
RATIONALE: Pralatrexate may stop the growth of tumor cells by blocking some...
Status
Completed
Location
Ohio State University
Start Date
2010-07
Trial ID
NCT01129206
Treatments Being Tested